NRx Pharmaceuticals - 8 Year Stock Price History | NRXP

Historical daily share price chart and data for NRx Pharmaceuticals since 2017 adjusted for splits and dividends. The latest closing stock price for NRx Pharmaceuticals as of June 25, 2025 is 3.27.
  • The all-time high NRx Pharmaceuticals stock closing price was 627.10 on February 02, 2021.
  • The NRx Pharmaceuticals 52-week high stock price is 6.01, which is 83.8% above the current share price.
  • The NRx Pharmaceuticals 52-week low stock price is 1.10, which is 66.4% below the current share price.
  • The average NRx Pharmaceuticals stock price for the last 52 weeks is 2.15.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
NRx Pharmaceuticals Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2025 2.6407 2.9900 5.1000 1.7100 3.2700 48.64%
2024 2.8575 4.9900 7.0100 1.1600 2.2000 -52.17%
2023 5.6742 12.1000 14.0000 2.3200 4.6000 -58.56%
2022 15.5261 49.7000 50.4000 5.0800 11.1000 -76.78%
2021 204.9397 240.1000 627.1000 45.0000 47.8000 -80.41%
2020 114.8012 106.0000 383.6000 104.5000 244.0000 130.19%
2019 104.3408 101.6000 108.0000 101.6000 106.0000 3.92%
2018 99.1604 96.9000 102.0000 96.8000 102.0000 5.37%
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.056B $0.000B
NRX Pharmaceuticals Inc. is a patient-focused, clinical stage pharmaceutical company. It creates therapies to treat diseases where no medicines currently exist. NRX Pharmaceuticals Inc., formerly known as Big Rock Partners Acquisition Corp., is based in RADNOR, Pa.
Stock Name Country Market Cap PE Ratio
Chugai Pharmaceutical (CHGCY) Japan $85.929B 32.24
Zoetis (ZTS) United States $70.240B 26.21
Takeda Pharmaceutical (TAK) Japan $47.983B 9.54
Daiichi Sankyo, - (DSNKY) Japan $44.148B 22.63
BeOne Medicines - (ONC) Cayman Islands $29.241B 0.00
Sandoz Group AG (SDZNY) Switzerland $23.170B 0.00
Merck (MKKGY) Germany $16.905B 12.39
Summit Therapeutics (SMMT) United States $15.537B 0.00
Shionogi (SGIOY) Japan $14.870B 14.90
United Therapeutics (UTHR) United States $13.078B 11.57
Neurocrine Biosciences (NBIX) United States $12.685B 43.45
Orion OYJ (ORINY) Finland $10.469B 28.31
IPSEN (IPSEY) France $9.739B 0.00
Corcept Therapeutics (CORT) United States $8.141B 66.18
Stevanato Group S.p.A (STVN) Italy $7.447B 45.54
Madrigal Pharmaceuticals (MDGL) United States $6.327B 0.00
Ionis Pharmaceuticals (IONS) United States $6.309B 0.00
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $6.153B 0.00
Grifols, S.A (GRFS) Spain $5.872B 0.00
Ono Pharmaceutical (OPHLF) Japan $5.031B 15.30
Soleno Therapeutics (SLNO) United States $4.242B 0.00
Crinetics Pharmaceuticals (CRNX) United States $2.897B 0.00
Hypermarcas (HYPMY) Brazil $2.850B 18.75
Catalyst Pharmaceuticals (CPRX) United States $2.692B 9.43
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.548B 13.78
BioCryst Pharmaceuticals (BCRX) United States $2.078B 0.00
NewAmsterdam Pharma (NAMS) Netherlands $2.066B 0.00
Indivior (INDV) United States $1.919B 8.14
Centessa Pharmaceuticals (CNTA) United Kingdom $1.896B 0.00
ARS Pharmaceuticals (SPRY) United States $1.648B 0.00
Endo (NDOI) United States $1.595B 0.00
Evotec AG (EVO) Germany $1.449B 0.00
Ocular Therapeutix (OCUL) United States $1.448B 0.00
Guardian Pharmacy Services (GRDN) United States $1.304B 0.00
Dyne Therapeutics (DYN) United States $1.208B 0.00
Harrow (HROW) United States $1.163B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.088B 21.76
Enliven Therapeutics (ELVN) United States $1.038B 0.00
Verve Therapeutics (VERV) United States $0.996B 0.00
Collegium Pharmaceutical (COLL) United States $0.967B 5.22
Akebia Therapeutics (AKBA) United States $0.964B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.929B 0.00
Ardelyx (ARDX) United States $0.880B 0.00
Elite Pharmaceuticals (ELTP) United States $0.828B 0.00
Cronos Group (CRON) Canada $0.729B 0.00
Xeris Biopharma Holdings (XERS) United States $0.729B 0.00
Liminatus Pharma (LIMN) United States $0.694B 0.00
Xencor (XNCR) United States $0.589B 0.00
Altimmune (ALT) United States $0.583B 0.00
KalVista Pharmaceuticals (KALV) United States $0.582B 0.00
USANA Health Sciences (USNA) United States $0.572B 12.43
Amylyx Pharmaceuticals (AMLX) United States $0.571B 0.00
Relay Therapeutics (RLAY) United States $0.567B 0.00
Regulus Therapeutics (RGLS) United States $0.565B 0.00
Bioventus (BVS) United States $0.555B 14.08
Theravance Biopharma (TBPH) United States $0.534B 0.00
Zevra Therapeutics (ZVRA) United States $0.500B 0.00
AleAnna (ANNA) United States $0.484B 0.00
Siga Technologies (SIGA) United States $0.457B 9.55
Oruka Therapeutics (ORKA) United States $0.440B 0.00
Organogenesis (ORGO) United States $0.439B 0.00
Tourmaline Bio (TRML) United States $0.435B 0.00
Savara (SVRA) United States $0.394B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.334B 9.03
Heron Therapeutics (HRTX) United States $0.328B 0.00
Aquestive Therapeutics (AQST) United States $0.319B 0.00
Nektar Therapeutics (NKTR) United States $0.304B 0.00
Nature's Sunshine Products (NATR) United States $0.279B 25.59
Tonix Pharmaceuticals Holding (TNXP) United States $0.262B 0.00
Esperion Therapeutics (ESPR) United States $0.212B 0.00
MediWound (MDWD) Israel $0.211B 0.00
OmniAb (OABI) United States $0.209B 0.00
Nanobiotix S.A (NBTX) France $0.208B 0.00
Aldeyra Therapeutics (ALDX) United States $0.201B 0.00
Larimar Therapeutics (LRMR) United States $0.191B 0.00
ProKidney (PROK) United States $0.189B 0.00
Profound Medical (PROF) Canada $0.186B 0.00
4D Molecular Therapeutics (FDMT) United States $0.185B 0.00
Aclaris Therapeutics (ACRS) United States $0.165B 0.00
Innate Pharma SA (IPHYF) France $0.163B 0.00
Journey Medical (DERM) United States $0.162B 0.00
Galectin Therapeutics (GALT) United States $0.153B 0.00
Lyell Immunopharma (LYEL) United States $0.142B 0.00
Lexeo Therapeutics (LXEO) United States $0.140B 0.00
Achieve Life Sciences (ACHV) Canada $0.132B 0.00
Avita Medical (RCEL) United States $0.131B 0.00
VAXART, INC (VXRT) United States $0.128B 0.00
Inhibikase Therapeutics (IKT) United States $0.123B 0.00
Korro Bio (KRRO) United States $0.119B 0.00
Protara Therapeutics (TARA) United States $0.118B 0.00
Ironwood Pharmaceuticals (IRWD) United States $0.117B 0.00
Cardiol Therapeutics (CRDL) Canada $0.111B 0.00
Champions Oncology (CSBR) United States $0.108B 17.68
Corbus Pharmaceuticals Holdings (CRBP) United States $0.097B 0.00
Cassava Sciences (SAVA) United States $0.094B 0.00
Unicycive Therapeutics (UNCY) United States $0.088B 0.00
Nutriband (NTRB) United States $0.087B 0.00
Arch Biopartners (ACHFF) Canada $0.086B 0.00
Dominari Holdings (DOMH) United States $0.085B 0.00
Fractyl Health (GUTS) United States $0.083B 0.00
Pyxis Oncology (PYXS) United States $0.079B 0.00
ESSA Pharma (EPIX) Canada $0.077B 0.00
Surrozen (SRZN) United States $0.076B 0.00
Vivani Medical (VANI) United States $0.075B 0.00
Wellgistics Health (WGRX) United States $0.073B 0.00
Inotiv (NOTV) United States $0.067B 0.00
Assertio Holdings (ASRT) United States $0.061B 0.00
PMV Pharmaceuticals (PMVP) United States $0.060B 0.00
Rafael Holdings (RFL) United States $0.059B 0.00
Allergy Therapeutics (AGYTF) United Kingdom $0.059B 0.00
Metagenomi (MGX) United States $0.058B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.055B 0.00
Avalo Therapeutics (AVTX) United States $0.054B 0.00
Gain Therapeutics (GANX) United States $0.054B 0.00
Telomir Pharmaceuticals (TELO) United States $0.052B 0.00
Context Therapeutics (CNTX) United States $0.052B 0.00
Century Therapeutics (IPSC) United States $0.051B 0.00
Prelude Therapeutics (PRLD) United States $0.049B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.049B 36.67
Klotho Neurosciences (KLTO) United States $0.047B 0.00
Mural Oncology (MURA) Ireland $0.042B 0.00
Karyopharm Therapeutics (KPTI) United States $0.040B 0.00
ElectroCore (ECOR) United States $0.040B 0.00
Iterum Therapeutics (ITRM) Ireland $0.039B 0.00
Acrivon Therapeutics (ACRV) United States $0.039B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.038B 0.00
Jupiter Neurosciences (JUNS) United States $0.037B 0.00
PolyPid (PYPD) Israel $0.036B 0.00
SCYNEXIS (SCYX) United States $0.029B 0.00
China SXT Pharmaceuticals (SXTC) China $0.029B 0.00
Enlivex Therapeutics (ENLV) Israel $0.028B 0.00
Tempest Therapeutics (TPST) United States $0.026B 0.00
FibroGen (FGEN) United States $0.022B 0.00
Natural Alternatives (NAII) United States $0.021B 0.00
DURECT (DRRX) United States $0.020B 0.00
BioVie (BIVI) United States $0.020B 0.00
Relmada Therapeutics (RLMD) United States $0.020B 0.00
BioLineRx (BLRX) Israel $0.019B 0.00
Carisma Therapeutics (CARM) United States $0.018B 0.00
Mannatech (MTEX) United States $0.017B 0.00
Vivos Therapeutics (VVOS) United States $0.017B 0.00
Lipocine (LPCN) United States $0.017B 0.00
Lyra Therapeutics (LYRA) United States $0.017B 0.00
CASI Pharmaceuticals (CASI) China $0.017B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.016B 0.00
VYNE Therapeutics (VYNE) United States $0.016B 0.00
Ernexa Therapeutics (ERNA) United States $0.015B 0.00
ProPhase Labs (PRPH) United States $0.015B 0.00
Citius Pharmaceuticals (CTXR) United States $0.014B 0.00
TherapeuticsMD (TXMD) United States $0.014B 0.00
Cosmos Health (COSM) United States $0.013B 0.00
Minerva Neurosciences (NERV) United States $0.013B 2.20
Scienture Holdings (SCNX) United States $0.012B 0.00
Phio Pharmaceuticals (PHIO) United States $0.011B 0.00
Mangoceuticals (MGRX) United States $0.010B 0.00
Ainos (AIMD) United States $0.010B 0.00
GlycoMimetics (CBIO) United States $0.010B 0.00
Addex Therapeutics (ADXN) Switzerland $0.009B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.009B 0.00
Talphera (TLPH) United States $0.009B 0.00
Traws Pharma (TRAW) United States $0.009B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.008B 0.00
Alaunos Therapeutics (TCRT) United States $0.008B 0.00
Biomerica (BMRA) United States $0.008B 0.00
Nuvilex (PMCB) United States $0.007B 0.00
Indaptus Therapeutics (INDP) United States $0.007B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.007B 0.00
TransCode Therapeutics (RNAZ) United States $0.006B 0.00
Incannex Healthcare (IXHL) Australia $0.006B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.005B 0.00
Aptorum Group (APM) United Kingdom $0.005B 0.00
Xenetic Biosciences (XBIO) United States $0.005B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.005B 0.00
InMed Pharmaceuticals (INM) Canada $0.005B 0.00
Redhill Biopharma (RDHL) Israel $0.004B 0.00
SHINECO (SISI) China $0.004B 0.00
Clearmind Medicine (CMND) Canada $0.004B 0.00
CERo Therapeutics Holdings (CERO) United States $0.004B 0.00
SciSparc (SPRC) Israel $0.004B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.003B 0.00
Heatwurx (PCSA) United States $0.003B 0.00
Plus Therapeutics (PSTV) United States $0.003B 0.00
Jaguar Animal Health (JAGX) United States $0.003B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.003B 0.00
XORTX Therapeutics (XRTX) Canada $0.003B 0.00
PainReform (PRFX) Israel $0.003B 0.00
Aditxt (ADTX) United States $0.003B 0.00
Qualigen Therapeutics (QLGN) United States $0.003B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.003B 0.00
TNF Pharmaceuticals (TNFA) United States $0.002B 0.00
Conduit Pharmaceuticals (CDT) United States $0.002B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.002B 0.00
Universe Pharmaceuticals INC (UPC) China $0.000B 0.00
4D Pharma (LBPS) United Kingdom $0.000B 0.00
MEI Pharma (MEIP) United States $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Silence Therapeutics (SLN) United Kingdom $0.000B 0.00